If these areas of mGluR5 underactivity were more extensive in human FXS brain, then learning might actually be impaired by an mGluR5 NAM, and this could provide an explanation for the observation of less language learning in the AFQ056 group during the placebo-controlled phase of FXLEARN. Here, GRM5 is linked to fragile X syndrome.